Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2695 |
|
Actual shortage: | 246 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2440 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
26 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TERIPARATIDE INJECTION | 250MCG | SOLUTION | Resolved | 2022-10-28 | 2022-12-15 | 173004 |
TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2022-12-01 | 2022-12-15 | 176800 |
TEVA-ZOPICLONE | 7.5MG | TABLET | Resolved | 2022-12-08 | 2022-12-15 | 177532 |
TEVA-ZOPICLONE | 7.5MG | TABLET | Resolved | 2020-09-11 | 2022-12-15 | 124110 |
AMPICILLIN SODIUM FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Resolved | 2022-03-31 | 2022-12-20 | 157650 |
AMPICILLIN SODIUM FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2022-01-27 | 2022-12-20 | 153739 |
TEVA-DEXTROAMPHETAMINE SR | 15MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2022-12-01 | 2022-12-22 | 176821 |
PORTIA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-08 | 2022-12-22 | 177502 |
PORTIA 28 | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-08 | 2022-12-22 | 177505 |
SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176815 |
TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2022-08-18 | 2022-12-22 | 167237 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176824 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2022-09-30 | 2022-12-22 | 170792 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176812 |
TEVA-CODEINE | 15MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165444 |
TEVA-CODEINE | 30MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165436 |
TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2022-09-22 | 2022-12-22 | 169957 |
TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2022-04-28 | 2022-12-22 | 159593 |
TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-05-19 | 2022-12-22 | 161003 |
TEVA-RISPERIDONE | 1.0MG | TABLET | Resolved | 2022-09-22 | 2022-12-22 | 170004 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Discontinued | 2023-11-27 | 2023-11-27 | 211558 |
TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |